DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-629 Cr | ₹-1,276 Cr | ₹-1,040 Cr | ₹-1,218 Cr | ₹-384 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DR REDDYS LABORATORIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2023 | ₹-629 Cr |
Mar2022 | ₹-1,276 Cr |
Mar2021 | ₹-1,040 Cr |
Mar2020 | ₹-1,218 Cr |
Mar2019 | ₹-384 Cr |
How is Deferred Tax Assets / Liabilities of DR REDDYS LABORATORIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹-629 Cr | Negative | |
Mar2022 | ₹-1,276 Cr | Negative | |
Mar2021 | ₹-1,040 Cr | Negative | |
Mar2020 | ₹-1,218 Cr | Negative | |
Mar2019 | ₹-384 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹103,501.1 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics | |
MANKIND PHARMA | ₹94,779.2 Cr | -1.4% | 1.4% | NA | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | 4.3% |
2.6% |
29.9% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses